BioPharma

Predefined Single-Use Production Platforms for Biomanufacturing


The biopharmaceutical industry can reduce the time and cost required to bring products to the clinic and the market by taking advantage of single-use production platforms. These platforms integrate proven services and technologies for the development and manufacture of mAbs, vaccines, and bioconjugates.

Companies can streamline early-stage process development activities by leveraging the expertise and experience Sartorius has acquired over many years while establishing biomanufacturing processes for clients. Furthermore, Sartorius can expedite the engineering of single-use and hybrid processes for scale-up during late-stage activities using process templates that reduce design costs and increase standardization.

Sartorius Biomanufacturing Platforms

  • mAbs

  • Vaccines

  • Blood and Plasma

    Discover our Technologies for Plasma Fractionation and Recombinant Blood Factors
  • Bioconjugation

  • Regenerative Medicine

  • Biosimilars

  • Intensified Processing

 

Product Categories

About Us

Malva continuously strives to maintain leadership in all aspects of its analytical solutions portfolio

Stay Connected on:

  

Contact us

Please feel free to contact us at:

 This email address is being protected from spambots. You need JavaScript enabled to view it.
(+30) 210-8000904
(+30) 210-8001424
Athens: 13 Ilission, Ν. Kifissia 14564
Thessaloniki: 26 D. Glinou, 54249